GEREMIE PALOMBARO

Allopathic & Osteopathic Physicians|Ophthalmology JOHNSON CITY, NY NPI 1760611016

General Payments — all program years on this page

$2,159.26

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 115
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $429.58 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $429.5821

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $243.1715
2019 $218.8613
2020 $47.953
2021 $307.0816
2022 $453.8523
2023 $458.7724
2024 $429.5821

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1110633168 Alcon Vision LLC $17.77 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111668630 Amgen Inc. $23.82 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111668632 Amgen Inc. $24.51 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111668634 Amgen Inc. $24.89 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111668636 Amgen Inc. $27.60 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139122260 Tarsus Pharmaceuticals, Inc. $21.19 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140348092 Bausch & Lomb Americas Inc. $23.13 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140348094 Bausch & Lomb Americas Inc. $20.24 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140348096 Bausch & Lomb Americas Inc. $24.28 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145441873 Organogenesis Inc. $32.50 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147406008 Oyster Point Pharma, Inc. $24.33 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147409943 Oyster Point Pharma, Inc. $22.21 08/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147410911 Oyster Point Pharma, Inc. $20.96 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147410917 Oyster Point Pharma, Inc. $19.55 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147411699 Oyster Point Pharma, Inc. $18.70 10/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147423871 Oyster Point Pharma, Inc. $1.26 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147423875 Oyster Point Pharma, Inc. $18.45 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147424231 Oyster Point Pharma, Inc. $21.78 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147425573 Oyster Point Pharma, Inc. $18.98 03/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147435395 Oyster Point Pharma, Inc. $16.16 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147435397 Oyster Point Pharma, Inc. $7.27 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.